Dr. Rajen Mody, MD, MS
Claim this profileC S Mott Children's Hospital
Expert in Neuroblastoma
Expert in Tumors
50 reported clinical trials
82 drugs studied
About Rajen Mody, MD, MS
Education:
- Earned an MD (Doctor of Medicine).
- Holds an MS (Master of Science).
Experience:
- Serves as Division Chief and Fellowship Program Director at the Pediatric Hematology/Oncology Fellowship Program, C.S. Mott Children's Hospital, University of Michigan.
- Recognized for expertise in pediatric hematology and oncology, covering both non-malignant and malignant disorders.
- Instrumental in developing a fellowship program aimed at nurturing future scientific investigators in pediatric hematology.
- Engages in cutting-edge research and clinical care, including precision medicine and genomic sequencing, for children.
Area of expertise
1Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
2Tumors
Global LeaderStage IV
NTRK1 positive
NTRK positive
Affiliated Hospitals
Clinical Trials Rajen Mody, MD, MS is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This study is evaluating whether genetic testing may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
CBL0137
for Cancer
This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous system (CNS) tumors or lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Drugs, such as CBL0137, block signals passed from one molecule to another inside a cell. Blocking these signals can affect many functions of the cell, including cell division and cell death, and may kill cancer cells.
Recruiting1 award Phase 1 & 213 criteria
More about Rajen Mody, MD, MS
Clinical Trial Related6 years of experience running clinical trials · Led 50 trials as a Principal Investigator · 20 Active Clinical TrialsTreatments Rajen Mody, MD, MS has experience with
- Dinutuximab
- Cyclophosphamide
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Ramucirumab
- Larotrectinib
Breakdown of trials Rajen Mody, MD, MS has run
Neuroblastoma
Tumors
Lymphoma
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajen Mody, MD, MS specialize in?
Rajen Mody, MD, MS focuses on Neuroblastoma and Tumors. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are Stage IV.
Is Rajen Mody, MD, MS currently recruiting for clinical trials?
Yes, Rajen Mody, MD, MS is currently recruiting for 14 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Rajen Mody, MD, MS has studied deeply?
Yes, Rajen Mody, MD, MS has studied treatments such as Dinutuximab, Cyclophosphamide, Cytology Specimen Collection Procedure.
What is the best way to schedule an appointment with Rajen Mody, MD, MS?
Apply for one of the trials that Rajen Mody, MD, MS is conducting.
What is the office address of Rajen Mody, MD, MS?
The office of Rajen Mody, MD, MS is located at: C S Mott Children's Hospital, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the C S Mott Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.